Fundraising Fox
/Companies
Sign in

Shield Bio

DefunctYC S16

San Francisco, US · 28 employees · 13 known investors

Find your way into Shield Bio

Sign up to see every warm intro you have to Shield Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Shield Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Shield Bio develops nanopore sequencing technology for clinical use, designed to run rapid genetic tests in healthcare settings. The company initially targets infectious disease diagnosis and sepsis detection to reduce treatment delays.

Also known as Shield Diagnostics Corp. · TL Biolabs Corp. · Shield Diagnostics · TL Biolabs · TL Biolabs, Shield Diagnostics

HealthtechMedical DevicesHealthcareGenomicsNanotechnologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S16)

FTFred Turner
Fred TurnerFounder · CEO2018–2020Fred Turner is founder and CEO of Shield Bio, which develops nanopore sequencing technology for rapid genetic testing in clinical settings, with an initial focus on infectious disease and sepsis detection.
SP
Sam Parlett
SO
Shahar Or-Geva

Investors · 13

Andreessen HorowitzreportedMenlo Park · $500K – $50M

How we know: funding news · Y Combinator's founder network · Not right? Tell us

Civilization Ventures Management, LlcreportedTiburon · $1M – $10M

How we know: Y Combinator's founder network · Not right? Tell us

Esas Venturesreported

How we know: Y Combinator's founder network · Not right? Tell us

FrialereportedNashville · $100K – $600K

How we know: Y Combinator's founder network · Not right? Tell us

Intuition CapitalreportedNew York

How we know: Y Combinator's founder network · Not right? Tell us

Knollwood Investment AdvisoryreportedHunt Valley

How we know: Y Combinator's founder network · Not right? Tell us

Refactor CapitalreportedBurlingame · $1M – $2M

How we know: funding news · Y Combinator's founder network · Not right? Tell us

SGH CapitalreportedParis

How we know: Y Combinator's founder network · Not right? Tell us

Soma CapitalreportedSacramento · $100K – $300K

How we know: funding news · Y Combinator's founder network · Not right? Tell us

Tectonic CapitalreportedHouston

How we know: Y Combinator's founder network · Not right? Tell us

Valia VenturesreportedLondon · $50K – $50M

How we know: a partner's Signal profile · funding news · Not right? Tell us

Zeno VenturesreportedGeneva

How we know: Y Combinator's founder network · Not right? Tell us

Founder mafia

2 people who came through Shield Bio went on to found or lead other companies.

Fred TurnerCEOFounded TL Biolabs +2Isaac TurnerDirector of Software and BioinformaticsFounded Curative

Related companies · 5

Kern SystemsKern Systems develops a cold data storage platform using synthetic DNA molecules and enzymes to archive data with superior density, durability, and energy efficiency compared to traditional storage technologies. The platform targets the growing market for long-term archival storage of rarely-accessed unstructured data.
Helix NanotechnologiesHelix Nanotechnologies develops mRNA-based therapeutics for disease treatment and environmental applications, currently advancing a COVID-19 vaccine candidate for immunocompromised patients and testing interventions targeting climate challenges.
KeylikaKeylika develops a platform synthesis technology for mixed ligand metal complexes to generate organometallic drugs for treating therapeutic conditions including hematology, pain, inflammation, metabolic disorders, infectious diseases, and oncology. The company combines drug development with drug delivery technologies, customizing molecular structure and formulation to optimize clinical outcomes for women, children, elderly, and patients with specific diseases.
InvitrisInvitris develops cell-free protein synthesis platforms that enable rapid design, expression, and scalable production of complex proteins for biopharmaceuticals, industrial biotechnology, and agriculture.
Nomic BioNomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies. It targets researchers doing proteomics work, aiming for high-throughput, low-cost profiling in the biotech and life sciences market.

Companies working in the same space as Shield Bio.

Legal entities · 2

corporate structure
Shield Diagnostics Corp.
TL Biolabs Corp.

Frequently asked questions

What does Shield Bio do?
Shield Bio develops nanopore sequencing technology for clinical use, designed to run rapid genetic tests in healthcare settings. The company initially targets infectious disease diagnosis and sepsis detection to reduce treatment delays.
Who founded Shield Bio?
Shield Bio was founded by Fred Turner.
Who are Shield Bio's investors?
Shield Bio's investors include Y Combinator, Andreessen Horowitz, Civilization Ventures Management, Llc, Esas Ventures, Friale, Intuition Capital, Knollwood Investment Advisory, Refactor Capital and 5 more.
Where is Shield Bio headquartered?
Shield Bio is headquartered in San Francisco, US.